| Name | Title | Contact Details |
|---|
With a history of over 25 years, Ceto has forged enduring partnerships with over 2,000 regional and community banks and credit unions nationwide, igniting their profitability and growth. Our unwavering commitment lies in empowering financial institutions with cutting-edge intelligence and transformative solutions, elevating shareholder value, and fostering thriving, prosperous communities. Discover more at ceto.com or dial 866.227.1361 to embark on a transformative journey.
The mission of Nevada Legal Services is to strengthen the community by ensuring fairness and providing equal access to justice for low income Nevadans. NLS receives the Legal Services Corporation funding for the state of Nevada. We represent qualified individuals in subsidized housing applications, terminations, and eviction, unemployment insurance benefits, Social Security disability appeals, welfare benefits, tax controveries, and limited immigration and family law.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Grant Thornton una de las firmas líderes a nivel mundial de servicios profesionales de Auditoría, Consultoría de Negocio, Tecnología e Innovación y Asesoramiento Fiscal, Legal, Financiero, Laboral y Outsourcing. Pertenecemos a una de las organizaciones y red líderes en servicios profesionales en todo el mundo, Grant Thornton International, con más de 73.000 profesionales presentes en más de 147 mercados. En España contamos con un equipo multidisciplinar, transversal, con experiencia y visión empresarial, que da servicio a más de 4.000 clientes en 10 oficinas repartidas por el territorio nacional: Madrid, Barcelona, Bilbao, Castellón, Las Palmas, Murcia, Valencia, Pamplona y Zaragoza.